1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Next Generation Cancer Diagnostic Devices Revenue
1.4 Market Analysis by Type
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 Lab-on- a- chip (LOAC)
1.4.5 Protein Microarrays
1.4.6 DNA Microarrays
1.4.7 Reverse Transcriptase-PCR (RT-PCR)
1.5 Market by Application
1.5.1 Global Next Generation Cancer Diagnostic Devices Market Share by Application: 2021-2026
1.5.2 Biomarker Development
1.5.3 CTC Analysis
1.5.4 Proteomic Analysis
1.5.5 Epigenetic Analysis
1.5.6 Genetic Analysis
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Next Generation Cancer Diagnostic Devices Market
1.8.1 Global Next Generation Cancer Diagnostic Devices Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Next Generation Cancer Diagnostic Devices Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Next Generation Cancer Diagnostic Devices Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Next Generation Cancer Diagnostic Devices Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Next Generation Cancer Diagnostic Devices Sales Volume Market Share by Region (2015-2020)
3.2 Global Next Generation Cancer Diagnostic Devices Sales Revenue Market Share by Region (2015-2020)
3.3 North America Next Generation Cancer Diagnostic Devices Sales Volume
3.3.1 North America Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.3.2 North America Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Next Generation Cancer Diagnostic Devices Sales Volume
3.4.1 East Asia Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.5.1 Europe Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.6.1 South Asia Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.7.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.8.1 Middle East Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.9.1 Africa Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.10.1 Oceania Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.11.1 South America Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.11.2 South America Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Next Generation Cancer Diagnostic Devices Sales Volume (2015-2020)
3.12.1 Rest of the World Next Generation Cancer Diagnostic Devices Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Next Generation Cancer Diagnostic Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Next Generation Cancer Diagnostic Devices Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Next Generation Cancer Diagnostic Devices Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Next Generation Cancer Diagnostic Devices Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Next Generation Cancer Diagnostic Devices Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Next Generation Cancer Diagnostic Devices Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Next Generation Cancer Diagnostic Devices Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Next Generation Cancer Diagnostic Devices Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Next Generation Cancer Diagnostic Devices Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Next Generation Cancer Diagnostic Devices Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Next Generation Cancer Diagnostic Devices Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Next Generation Cancer Diagnostic Devices Sales Volume Market Share by Type (2015-2020)
14.2 Global Next Generation Cancer Diagnostic Devices Sales Revenue Market Share by Type (2015-2020)
14.3 Global Next Generation Cancer Diagnostic Devices Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Next Generation Cancer Diagnostic Devices Consumption Volume by Application (2015-2020)
15.2 Global Next Generation Cancer Diagnostic Devices Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Next Generation Cancer Diagnostic Devices Business
16.1 Roche Holding Ltd.?Switzerland)
16.1.1 Roche Holding Ltd.?Switzerland) Company Profile
16.1.2 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product Specification
16.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Affymetrix Inc.(US)
16.2.1 Affymetrix Inc.(US) Company Profile
16.2.2 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.2.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Agilent Technologies Inc(Germany)
16.3.1 Agilent Technologies Inc(Germany) Company Profile
16.3.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Specification
16.3.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Abbott Laboratories(US)
16.4.1 Abbott Laboratories(US) Company Profile
16.4.2 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Specification
16.4.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 QIAGEN N.V.(Germany)
16.5.1 QIAGEN N.V.(Germany) Company Profile
16.5.2 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Specification
16.5.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Siemens Healthcare(Germany)
16.6.1 Siemens Healthcare(Germany) Company Profile
16.6.2 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Specification
16.6.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Thermo Fisher Scientific Inc.(US)
16.7.1 Thermo Fisher Scientific Inc.(US) Company Profile
16.7.2 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.7.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Becton Dickinson and Co.(US)
16.8.1 Becton Dickinson and Co.(US) Company Profile
16.8.2 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.8.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Illumina Inc.(US)
16.9.1 Illumina Inc.(US) Company Profile
16.9.2 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.9.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Johnson & Johnson(US)
16.10.1 Johnson & Johnson(US) Company Profile
16.10.2 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Specification
16.10.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Allegro Diagnostics Corp.(Brazil)
16.11.1 Allegro Diagnostics Corp.(Brazil) Company Profile
16.11.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Specification
16.11.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 GE Healthcare(England)
16.12.1 GE Healthcare(England) Company Profile
16.12.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Specification
16.12.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Cepheid Inc.(US)
16.13.1 Cepheid Inc.(US) Company Profile
16.13.2 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.13.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Life Technologies Corp.(US)
16.14.1 Life Technologies Corp.(US) Company Profile
16.14.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.14.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Luminex Corp.(US)
16.15.1 Luminex Corp.(US) Company Profile
16.15.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Specification
16.15.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
17.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
17.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Next Generation Cancer Diagnostic Devices Distributors List
18.3 Next Generation Cancer Diagnostic Devices Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Next Generation Cancer Diagnostic Devices (2021-2026)
20.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices (2021-2026)
20.3 Global Forecasted Price of Next Generation Cancer Diagnostic Devices (2015-2026)
20.4 Global Forecasted Production of Next Generation Cancer Diagnostic Devices by Region (2021-2026)
20.4.1 North America Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.3 Europe Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.7 Africa Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.9 South America Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.2 East Asia Market Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.3 Europe Market Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Countriy
21.4 South Asia Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.5 Southeast Asia Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.6 Middle East Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.7 Africa Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.8 Oceania Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.9 South America Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
21.10 Rest of the world Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer